
Positions en cours
Date | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
17/05/23 | MEDIAN TECHNOLOGIES | Achat | 4 000 E | 4.30 | 2.28 | -47.28% | -1 891 | ![]() |
0 |
03/05/23 | OSE IMMUNOTHERAPEUTICS | Achat | 2 000 E | 3.82 | 6.79 | 77.19% | 1 544 | ![]() |
0 |
11/01/23 | INTEGRAGEN | Achat | 2 000 E | 1.37 | 0.52 | -61.96% | -1 239 | ![]() |
1 |
11/01/23 | INTEGRAGEN | Achat | 2 000 E | 1.37 | 0.52 | -61.96% | -1 239 | ![]() |
1 |
11/01/23 | INTEGRAGEN | Achat | 2 000 E | 1.37 | 0.52 | -61.96% | -1 239 | ![]() |
1 |
04/10/22 | ADVICENNE | Achat | 2 000 E | 4.00 | 2.05 | -49.05% | -981 | ![]() |
2 |
04/10/22 | ADVICENNE | Achat | 2 000 E | 4.00 | 2.05 | -49.05% | -981 | ![]() |
2 |
04/10/22 | OSE IMMUNOTHERAPEUTICS | Achat | 1 000 E | 4.90 | 6.79 | 38.09% | 381 | ![]() |
3 |
05/09/22 | OSE IMMUNOTHERAPEUTICS | Achat | 2 000 E | 7.68 | 6.79 | -11.97% | -239 | ![]() |
3 |
03/08/22 | OSE IMMUNOTHERAPEUTICS | Achat | 2 000 E | 6.50 | 6.79 | 4.05% | 81 | ![]() |
5 |
11/08/21 | ADVICENNE | Achat | 2 000 E | 7.31 | 2.05 | -72.21% | -1 444 | ![]() |
6 |
11/08/21 | ADVICENNE | Achat | 2 000 E | 7.31 | 2.05 | -72.21% | -1 444 | ![]() |
7 |
11/08/21 | ADVICENNE | Achat | 2 000 E | 7.31 | 2.05 | -72.21% | -1 444 | ![]() |
6 |
08/09/20 | INNATE PHARMA | Achat | 1 600 E | 3.80 | 1.92 | -49.52% | -792 | ![]() |
10 |
08/09/20 | INNATE PHARMA | Achat | 1 500 E | 4.05 | 1.92 | -52.64% | -790 | ![]() |
10 |
08/09/20 | INNATE PHARMA | Achat | 1 600 E | 4.20 | 1.92 | -54.34% | -869 | ![]() |
16 |
30/07/20 | INNATE PHARMA | Achat | 750 E | 5.04 | 1.92 | -61.96% | -465 | ![]() |
9 |
29/06/20 | INNATE PHARMA | Achat | 2 000 E | 5.70 | 1.92 | -66.38% | -1 328 | ![]() |
9 |
14/05/20 | OSE IMMUNOTHERAPEUTICS | Achat | 1 000 E | 6.16 | 6.79 | 10.02% | 100 | ![]() |
9 |
14/05/20 | OSE IMMUNOTHERAPEUTICS | Achat | 1 000 E | 6.16 | 6.79 | 10.02% | 100 | ![]() |
7 |
19/07/19 | INNATE PHARMA | Achat | 1 200 E | 5.72 | 1.92 | -66.50% | -798 | ![]() |
10 |
25/06/19 | INNATE PHARMA | Achat | 700 E | 5.65 | 1.92 | -66.08% | -463 | ![]() |
7 |
18/06/19 | INNATE PHARMA | Achat | 650 E | 5.94 | 1.92 | -67.74% | -440 | ![]() |
11 |
28/05/19 | INNATE PHARMA | Achat | 950 E | 5.82 | 1.92 | -67.07% | -637 | ![]() |
11 |
24/05/19 | OSE IMMUNOTHERAPEUTICS | Achat | 1 500 E | 3.76 | 6.79 | 80.30% | 1 205 | ![]() |
9 |
24/05/19 | INNATE PHARMA | Achat | 1 500 E | 5.85 | 1.92 | -67.24% | -1 009 | ![]() |
9 |
Enregistrements 1 à 26 sur 26 |
Positions soldées
Date sortie | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
29/08/24 | OSE IMMUNOTHERAPEUTICS | Achat | 800 E | 3.65 | 7.92 | 116.67% | 933 | ![]() |
11 |
29/08/24 | OSE IMMUNOTHERAPEUTICS | Achat | 800 E | 3.40 | 7.92 | 132.61% | 1 061 | ![]() |
11 |
05/01/23 | MAUNA KEA TECHNOLOGIES | Achat | 1 200 E | 1.11 | 0.42 | -62.30% | -748 | ![]() |
10 |
05/01/23 | MAUNA KEA TECHNOLOGIES | Achat | 1 200 E | 1.11 | 0.42 | -62.30% | -748 | ![]() |
8 |
05/01/23 | MAUNA KEA TECHNOLOGIES | Achat | 1 500 E | 1.11 | 0.42 | -62.30% | -935 | ![]() |
8 |
05/01/23 | MAUNA KEA TECHNOLOGIES | Achat | 1 000 E | 1.11 | 0.42 | -62.30% | -623 | ![]() |
8 |
05/01/23 | THERADIAG | Achat | 750 E | 2.62 | 2.28 | -13.16% | -99 | ![]() |
8 |
05/01/23 | THERADIAG | Achat | 500 E | 2.41 | 2.28 | -5.59% | -28 | ![]() |
11 |
05/01/23 | THERADIAG | Achat | 700 E | 1.94 | 2.28 | 17.31% | 121 | ![]() |
9 |
05/01/23 | THERADIAG | Achat | 1 100 E | 1.85 | 2.28 | 22.80% | 251 | ![]() |
7 |
05/01/23 | THERADIAG | Achat | 800 E | 1.85 | 2.28 | 22.80% | 182 | ![]() |
7 |
02/01/23 | POXEL | Achat | 2 000 E | 1.57 | 0.99 | -37.27% | -745 | ![]() |
2 |
02/01/23 | POXEL | Achat | 2 000 E | 1.59 | 0.99 | -38.06% | -761 | ![]() |
2 |
02/01/23 | GENSIGHT BIOLOGICS SA | Achat | 1 000 E | 3.89 | 3.43 | -12.01% | -120 | ![]() |
10 |
02/01/23 | GENSIGHT BIOLOGICS SA | Achat | 1 000 E | 3.87 | 3.43 | -11.56% | -116 | ![]() |
9 |
02/01/23 | GENSIGHT BIOLOGICS SA | Achat | 1 000 E | 3.87 | 3.43 | -11.56% | -116 | ![]() |
8 |
05/09/22 | INNATE PHARMA | Achat | 1 500 E | 2.78 | 2.60 | -6.86% | -103 | ![]() |
7 |
05/09/22 | INNATE PHARMA | Achat | 2 000 E | 2.70 | 2.60 | -4.10% | -82 | ![]() |
4 |
19/01/22 | ACTIA GROUP | Achat | 750 E | 2.25 | 4.57 | 102.81% | 771 | ![]() |
7 |
19/01/22 | ACTIA GROUP | Achat | 750 E | 2.25 | 4.57 | 102.81% | 771 | ![]() |
7 |
19/01/22 | ACTIA GROUP | Achat | 750 E | 2.20 | 4.57 | 107.42% | 806 | ![]() |
7 |
19/01/22 | ACTIA GROUP | Achat | 750 E | 2.20 | 4.57 | 107.42% | 806 | ![]() |
11 |
19/01/22 | ACTIA GROUP | Achat | 1 000 E | 2.31 | 4.57 | 97.54% | 975 | ![]() |
10 |
19/11/21 | THERADIAG
![]() |
DS | 0 E | 0.00 | 0.08 | 0.00% | 24 | ![]() |
3 |
19/11/21 | THERADIAG
![]() |
DS | 0 E | 0.00 | 0.08 | 0.00% | 17 | ![]() |
3 |
19/11/21 | THERADIAG
![]() |
DS | 0 E | 0.00 | 0.08 | 0.00% | 30 | ![]() |
1 |
19/11/21 | THERADIAG
![]() |
DS | 0 E | 0.00 | 0.08 | 0.00% | 49 | ![]() |
4 |
19/11/21 | THERADIAG
![]() |
DS | 0 E | 0.00 | 0.08 | 0.00% | 36 | ![]() |
3 |
25/10/21 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 750 E | 6.15 | 3.22 | -47.79% | -358 | ![]() |
10 |
25/10/21 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 500 E | 5.90 | 3.22 | -45.58% | -228 | ![]() |
8 |
25/10/21 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 500 E | 5.84 | 3.22 | -45.02% | -225 | ![]() |
6 |
25/10/21 | PHAXIAM THERAPEUTICS (ERYTECH) | Achat | 500 E | 5.84 | 3.20 | -45.36% | -227 | ![]() |
6 |
21/09/21 | L'OREAL | Achat | 10 000 E | 398.75 | 372.70 | -7.88% | -788 | ![]() |
4 |
21/09/21 | L'OREAL | Achat | 10 000 E | 398.85 | 372.70 | -7.90% | -790 | ![]() |
4 |
12/08/21 | SOCIETE GENERALE | Achat | 10 000 E | 27.54 | 27.52 | -0.50% | -50 | ![]() |
4 |
12/08/21 | SOCIETE GENERALE | Achat | 10 000 E | 27.54 | 27.52 | -0.50% | -50 | ![]() |
2 |
11/08/21 | TRANSGENE | Achat | 700 E | 1.78 | 2.27 | 27.30% | 191 | ![]() |
4 |
11/08/21 | TRANSGENE | Achat | 850 E | 1.78 | 2.27 | 27.30% | 232 | ![]() |
4 |
11/08/21 | TRANSGENE | Achat | 1 000 E | 1.79 | 2.27 | 26.59% | 266 | ![]() |
15 |
11/08/21 | REWORLD MEDIA | Achat | 1 000 E | 2.89 | 4.07 | 40.59% | 406 | ![]() |
7 |
11/08/21 | REWORLD MEDIA | Achat | 1 000 E | 2.89 | 4.07 | 40.59% | 406 | ![]() |
5 |
11/08/21 | REWORLD MEDIA | Achat | 1 000 E | 2.81 | 4.07 | 44.60% | 446 | ![]() |
4 |
11/08/21 | REWORLD MEDIA | Achat | 800 E | 2.81 | 4.07 | 44.60% | 357 | ![]() |
7 |
11/08/21 | REWORLD MEDIA | Achat | 800 E | 2.81 | 4.07 | 44.60% | 357 | ![]() |
4 |
11/08/21 | REWORLD MEDIA | Achat | 800 E | 2.81 | 4.07 | 44.60% | 357 | ![]() |
5 |
11/01/21 | NEXTEDIA | Achat | 800 E | 0.65 | 1.50 | 130.44% | 1 044 | ![]() |
9 |
11/01/21 | NEXTEDIA | Achat | 1 000 E | 0.59 | 1.50 | 153.88% | 1 539 | ![]() |
8 |
21/12/20 | VALNEVA SE | Achat | 500 E | 3.21 | 8.37 | 160.39% | 802 | ![]() |
6 |
13/11/20 | ACTIA GROUP
![]() |
DIV | 0 E | 0.00 | 0.15 | 0.00% | 50 | ![]() |
4 |
13/11/20 | ACTIA GROUP
![]() |
DIV | 0 E | 0.00 | 0.15 | 0.00% | 50 | ![]() |
4 |
Enregistrements 1 à 50 sur 170 |